Thrombin alpha biosimilar - RecpharmaAlternative Names: human recombinant thrombin alpha - Recpharma
Latest Information Update: 20 May 2015
At a glance
- Originator Recpharma
- Class Antihaemorrhagics; Blood coagulation factors; Serine endopeptidases
- Mechanism of Action Thrombin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Haemorrhage
Most Recent Events
- 20 May 2015 Early research in Haemorrhage in Iran (Topical) before May 2015